Shanghai Pediatric Cataract Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

10000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-01-01

Study Completion Date

2045-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the long-term visual outcome of the cataract surgery using a large-scale and comprehensive database of pediatric cataract participants, including congenital and traumatic cataract. The investigators will further investigate into the various genetic and environmental factors that may contribute to the pathogenesis of pediatric cataract.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Long-term Visual and Refractive Outcomes After Traumatic Cataract Surgery in Children

NCT07087275

Traumatic Cataract

ACTIVE_NOT_RECRUITING

Glaucoma Following Pediatric Cataract Surgery

NCT05451745

Glaucoma Following Pediatric Cataract Surgery Glaucoma Secondary Congenital Cataract

ACTIVE_NOT_RECRUITING

Prospective,Randomized,Controlled Study to Assess Efficacy,Safety, and Tolerability of SLT vs. PLT in Patients With POAG

NCT02231515

Glaucoma and Ocular Hypertension

TERMINATED NA

Lens Extraction Combined With Goniosynechialysis Versus Trabeculectomy

NCT04703712

Glaucoma, Angle-Closure

UNKNOWN NA

The Visual Plasticity During Adversity and Prosperity in Infants With Congenital Cataracts

NCT03593824

Cataract

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pediatric Cataract Congenital Cataract Traumatic Cataract Visual Outcome Genetic Anticipation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Congenital cataract group

Cataract patients diagnosed with congenital cataract.

intraocular lens implantation

Intervention Type PROCEDURE

1）Pediatric cataract patients with intraocular lens implantation and those without intraocular lens implantation；2）Traumatic cataract patients with intraocular lens implantation and those without intraocular lens implantation

Traumatic cataract group

Cataract patients diagnosed with traumatic cataract.

intraocular lens implantation

Intervention Type PROCEDURE

1）Pediatric cataract patients with intraocular lens implantation and those without intraocular lens implantation；2）Traumatic cataract patients with intraocular lens implantation and those without intraocular lens implantation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

intraocular lens implantation

1）Pediatric cataract patients with intraocular lens implantation and those without intraocular lens implantation；2）Traumatic cataract patients with intraocular lens implantation and those without intraocular lens implantation

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinical diagnosis of pediatric cataract
* Must be able to cooperate with the ophthalmic examination

Exclusion Criteria

* Clinical diagnosis of mental illness
* Mentally disabled

Minimum Eligible Age

2 Months

Maximum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR